MI GPSai™

For cancers of unknown primary or cases with atypical clinical presentation or clinical ambiguity, MI GPSai™ provide a cancer type similarity assessment by comparing the characteristics of a patient’s tumor against other tumors in the Caris database across 21 cancer categories.

MI FOLFOXai™

MI FOLFOXai™ is a revolutionary innovation which uses artificial intelligence and machine learning to identify patients that are likely to benefit from first-line treatment with FOLFOX.

FOLFOX Video